Melanoma Panel - Disclosures
Panel Member
|
Mark Albertini MD |
Grant/Research Support
|
| Anyxis Immuno-Oncology GmbH | Array BioPharma Inc | Bristol Myers Squibb | Erasca | Merck & Co., Inc. |
Date Completed
|
04/26/2025 |
Panel Member
|
Christopher Barker MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sarah Bateni MD, MAS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Joel Baumgartner MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Shailender Bhatia MD |
Grant/Research Support
|
| EMD Serono | Incyte Corporation |
Date Completed
|
03/09/2025 |
Panel Member
|
Christopher Bichakjian MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Marian Birkeland PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Genevieve Boland MD, PhD |
Equity Interest/Stock Options
|
| Ankyra Therapeutics |
Grant/Research Support
|
| Olink Proteomics | Teiko Bio |
Date Completed
|
07/22/2024 |
Panel Member
|
Sunandana Chandra MD, MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Chen MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Bartosz Chmielowski MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Dominick DiMaio MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Roxana Dronca MD |
Grant/Research Support
|
| BMS |
Date Completed
|
07/30/2024 |
Panel Member
|
Sara Espinosa PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Martin Fleming MD, FACS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Anjela Galan MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Samantha Guild JD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Siwen Hu-Lieskovan MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Douglas Johnson MD, MSCI |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Madeline Joyce BSN, RN, OCN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Giorgos Karakousis MD |
Grant/Research Support
|
| Merck & Co., Inc. |
Date Completed
|
11/27/2024 |
Panel Member
|
Ann Karosas RPh, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kari Kendra MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Maija Kiuru MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Julie Lange MD, ScM |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ryan Lanning MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Theodore Logan MD, FACP |
Grant/Research Support
|
| Abbott Laboratories | Abraxis Bioscience, Inc. | Acceleron Pharma, Inc. | Amgen Inc. | Argos Therapeutics | AstraZeneca Pharmaceuticals LP | AVEO Pharmaceuticals, Inc. | Biovex | Bristol Myers Squibb | Cerulean | Dynavax | Eisai Inc. | Eli Lilly and Company | EMD Serono | GSK | Iovance pharmaceuticals | MacroGenics | MedImmune Inc. | Merck & Co., Inc. | NiKang | Novartis Pharmaceuticals Corporation | Peloton Therapeutics, Inc. | Pfizer Inc. | Prometheus | Roche Laboratories, Inc. | Synta Pharmaceuticals Corp. | Threshold Pharmaceuticals | Tracon |
Date Completed
|
04/29/2025 |
Panel Member
|
Miguel Materin MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Christine McLaughlin |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole McMillian MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kelly Nelson MD, FAAD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Aaron Oliver PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Daniel Olson MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Anthony Olszanski MD, RPh |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Svitlana Ostanina PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Patrick Ott MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Igor Puzanov MD, MSCI, FACP |
Equity Interest/Stock Options
|
| IDEAYA |
Date Completed
|
06/10/2024 |
Panel Member
|
Luke Rothermel MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
April Salama MD |
Grant/Research Support
|
| Ascentage | Bristol Myers Squibb | Ideaya | Immunocore | Merck & Co., Inc. | Olatec Therapeutics | Regeneron Pharmactcls | Replimune | SeaGen |
Date Completed
|
08/09/2024 |
Panel Member
|
Rohit Sharma MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Arun Singh MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Andrew Stacey MD, MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Susan Swetter MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Katy Tsai MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evan Wuthrick MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Yan Xing MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |